Biochemicals and Reagents

<p>Tubacin is a natural compound that has been found to inhibit the histone deacetylase (HDAC) enzyme. Tubacin has shown significant cytotoxicity against cancer cells and other cells in vitro. It inhibits HDAC and prevents the acetylation of histones, which are proteins that package DNA strands into chromosomes. This inhibition leads to increased gene expression and cell death. Tubacin is not toxic to normal cells, but it does cause oxidative injury to neurons.</p>

<p>Lysine-specific inhibitor of histone demethylase (LSD1)</p>

<p>Amidephrine is a type of fatty acid that is used as a drug in the treatment of infectious diseases and certain types of cancer. It binds to cytosolic Ca2+, which increases the level of this ion in the cytosol and leads to an increase in intracellular cAMP levels. Amidephrine also acts as an agonist for 2-adrenergic receptors, leading to vasoconstriction and increased heart rate. The effects of Amidephrine are mediated by its binding to adrenergic receptors on fat cells, liver cells, and gland cells. The potency of Amidephrine is low due to its ability to cross the blood-brain barrier but not the blood-placenta barrier.<br>FATTY ACID: A class of organic compounds that are characterized by their chemical structure consisting only of carbon chains with one or more double bonds.<br>DIASTOLIC PRESSURE: The pressure exerted by blood against your artery walls when your heart relaxes between beats.</p>

<p>NSC 87877 is a chemical inhibitor that inhibits the activity of protein kinase C (PKC). It has been shown to inhibit the tyrosine phosphatase, leading to neuronal death. NSC 87877 also has angiogenic properties and can be used for the treatment of some cancers. The PKC inhibitors have been shown to decrease cellular proliferation and induce cell cycle arrest by interfering with signal pathways. This drug may be able to interfere with PKC-mediated signal cascades that regulate cell growth and differentiation, thereby providing a possible therapeutic target for cancer therapy.</p>

<p>24,25 Dihydroxyvitamin D3 (26,26,26,27,27,27-d6) is a radioactive form of vitamin D3. It is a peptide that belongs to the group of activators. The protein interactions of this compound are unknown and it has not been found to have any receptor activity. 24,25 Dihydroxyvitamin D3 (26,26,26,27,27,27-d6) is a ligand for ion channels and can be used as a research tool for cell biology and cell signaling. This radioactive vitamin D3 can be used to study the function of ion channels in different cells by binding to them. 24DHD3 (26DHD3), with its high purity and stability under physiological conditions, is an excellent research tool for studying the mechanisms of ion channel physiology in cells.</p>

<p>Inhibitor of histone deacetylase</p>

<p>Ribosomal S6 kinase inhibitor</p>

<p>Des-Arg9-Bradykinin is a peptide that is structurally related to bradykinin. It is synthesized by removing the first two amino acids from the N terminus of bradykinin and replacing them with an acetyl group. It has been shown to have potent activity against inflammatory cells in vitro, including mast cell degranulation and histamine release. Des-Arg9-Bradykinin also inhibits the production of nitric oxide, which may be responsible for its anti-inflammatory effects.</p>

<p>Deltarasin hydrochloride is a peptide inhibitor of the protein tyrosine kinase receptor. It has been shown to inhibit a number of receptors, including the LERK-2 receptor, which is expressed in peripheral nerve cells and is involved in pain transmission. Deltarasin hydrochloride is a high-purity reagent that can be used as a research tool for studying protein interactions and binding properties. The CAS number for this product is 1613404-76-4.</p>

<p>Seletalisib is a novel, potent, and selective inhibitor of the lipid kinase activity. It blocks protein synthesis by binding to the ribosomal protein S6 kinase-1 (RSK1) which is involved in regulating cell proliferation and differentiation. Seletalisib has been shown to be effective in clinical studies for treatment of autoimmune diseases such as systemic lupus erythematosus (SLE). This drug also has pharmacokinetic properties that are suitable for hepatic impairment. Seletalisib also inhibits the production of chemokines, which are inflammatory cytokines that induce chemotaxis of leukocytes and promote inflammation.</p>

<p>Inhibitor of BET bromodomain</p>

<p>Albiglutide Fragment is a fragment of the soybean trypsin inhibitor, which is a protein that has been found to inhibit the activity of pancreatic enzymes. The fragment was designed to be used in diagnosis and treatment of infectious diseases. Albiglutide Fragment binds to the glucagon-like peptide (GLP) receptors on cells in the intestine and pancreas, inhibiting the production of pro-inflammatory cytokines and reducing inflammation. When it is bound to GLP receptors, albiglutide fragment blocks cell signals that lead to diabetes, obesity, and metabolic syndrome. Albiglutide Fragment can also be used as a contrast agent for imaging techniques such as magnetic resonance imaging or ultrasound. It binds to cells in high concentrations and can help visualize profiles of these cells.</p>

<p>1-(7Z-Hexadecenoyl)-rac-glycerol is a monoacylglycerol, which is a type of lipid commonly found in various biological systems. This compound is typically derived from natural sources such as plant oils or synthesized for research purposes. Its mode of action involves acting as a signaling molecule within cell membranes, where it can influence various biochemical pathways. This lipid can interact with specific enzymes and receptors, contributing to cellular regulation processes.</p>

<p>Inhibitor of Aurora A kinase</p>

<p>18:1 Pi(4)P is a research tool that has been used to study the effects of phospholipids on ion channels and receptors. The compound is an inhibitor of ligand-gated ion channels, such as nicotinic acetylcholine receptors and glycine receptors. It has also been shown to interact with peptides and antibodies. 18:1 Pi(4)P is not expected to have any adverse side effects, but it should be handled with care because it is a potent cytotoxic agent.</p>

<p>Ast2818 mesylate is a small-molecule, orally active, selective factor receptor tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) and its downstream signaling proteins. Ast2818 mesylate binds to the EGFR at a site distinct from the ATP binding site and prevents phosphorylation by protein tyrosine kinases. It inhibits cell proliferation by blocking the activation of downstream signaling proteins such as Ras, Raf, and Akt. The compound has been evaluated in preclinical studies for potential use as an antineoplastic agent in lung cancer. In these studies, Ast2818 mesylate inhibited tumor growth in mouse models of lung cancer. Further analysis showed that this effect was due to inhibition of epidermal growth factor receptor-mediated signaling pathways involved in cell proliferation and tumorigenesis.</p>

<p>IL1-beta is a pro-inflammatory cytokine that belongs to the Interleukin family. It is expressed in response to inflammation, trauma, and infection and can be found in many tissues of the body. IL1-beta has been shown to have a wide variety of effects on the body including regulating cell growth and differentiation. IL1-beta has also been shown to bind with high affinity to specific receptors that are known as type I interleukins. These receptors are able to activate other cells such as T cells and macrophages, which produce more inflammatory cytokines such as tumor necrosis factor alpha (TNFα) and interferon gamma (IFNγ).<br>IL1-beta Mouse is a mouse monoclonal antibody that binds specifically with IL1-beta. This antibody can be used for immunohistochemistry or Western blotting experiments. It can also be used for blocking studies using an ELISA assay or RIA assay.</p>

<p>SCR-1481B1 is an innovative nanocarrier system, which is developed from biomimetic polymers with ligand-targeted capabilities. This system functions by leveraging surface-functionalized nanoparticles to deliver therapeutic agents directly to specific cell types, thereby enhancing efficacy and reducing off-target effects. The intricate design of SCR-1481B1 allows it to bypass common biological barriers and achieve high-efficiency delivery, making it a compelling tool in precision medicine.</p>

<p>N-(2-Aminoethyl)-N-[[3-methoxy-4-(phenylmethoxy)phenyl]methyl]-carbamic acid (1S)-1-phenylethyl ester is a peptide that has been shown to inhibit the interactions of proteins. It also has been found to be an activator of protein interactions and ligand for a receptor or ion channel. N-(2-Aminoethyl)-N-[(3-methoxy-4-(phenylmethoxy)phenyl]methyl]-carbamic acid (1S)-1-phenylethyl ester is used in research as a tool for studying the structure, function, and regulation of proteins and ions channels.</p>

<p>Neuromedin U is a peptide that plays a role in the regulation of cardiovascular function and the modulation of pain. It has been found to activate receptors for calcitonin gene-related peptide (CGRP) and vasoactive intestinal peptide (VIP). Neuromedin U has also been found to be an inhibitor of ligand-induced activation of ion channels, such as those activated by bradykinin or histamine. This protein can be used as a research tool in cell biology, pharmacology, and biochemistry.</p>

<p>BMS 509744 is a tyrosine kinase inhibitor. It inhibits the activation of the signal pathways that are involved in the proliferation of t-cells. BMS 509744 has been shown to be effective in inhibiting cancer cells, with a particular focus on T-cell lymphomas. The drug also inhibits inflammation by inhibiting toll-like receptor. This drug has been shown to have an effective dose of 10mg in animal studies and is currently undergoing clinical trials for use against inflammatory diseases, such as rheumatoid arthritis and psoriasis.</p>

<p>TED-347 is a covalent inhibitor of the transcriptional coactivator p300. The inhibition of p300 blocks the interaction with DNA and leads to a reduced level of gene expression. TED-347 has shown inhibitory effects on pleural mesothelioma, cancer and other types of diseases. Structural biology experiments have been performed on TED-347 to identify its binding site in mammalian cells. This drug has also been shown to be effective against microcontroller-induced cellular growth factor expression in vitro and in vivo.</p>

<p>GSK481 is an investigational therapeutic product, which is a pharmaceutical compound developed by the global healthcare company GlaxoSmithKline (GSK). The source of this compound derives from extensive medicinal chemistry and drug development processes aimed at addressing specific molecular targets. GSK481 functions through a targeted mode of action that modulates particular biochemical pathways implicated in disease pathophysiology. The compound's mechanism involves binding to specific molecular targets to inhibit or modify their activity, thereby altering the progression of the disease process.</p>

<p>653-47 is a synthetic peptide that binds to the extracellular domain of the human angiotensin II type 1 receptor. It has been shown to be an inhibitor of protein interactions and activator of ligand-receptor interactions. 653-47 is used as a research tool for studying the role of angiotensin II receptors in cell biology and as a reagent for antibody production. 653-47 is also used as an ion channel blocker. This peptide has high purity, and can be obtained from many manufacturers.</p>

<p>Sevoflurane is an experimental drug that belongs to the group of intravenous anaesthetics. It has been shown to be effective in the prevention and treatment of myocardial infarcts. Sevoflurane inhibits polymerase chain reaction by binding to dinucleotide phosphate, which prevents DNA synthesis. It also inhibits oxidative injury in the heart, as well as genotoxic activity. Sevoflurane is a potent chemical inhibitor of the ryanodine receptor, which regulates calcium release from the sarcoplasmic reticulum. This inhibition results in reduced contractility and relaxation of vascular smooth muscle cells, leading to vasodilation and increased blood flow.</p>

<p>4,4'-(7-Hydroxychroman-3,4-diyl)diphenol (DHP) is a synthetic small molecule that is being studied for its anticancer activity. DHP has been shown to inhibit mitochondrial membrane potential, which is essential for tumor cell proliferation and metastasis. DHP has also been shown to have toxicities in vivo, including increased levels of liver enzymes in mice. This drug has been used as a probe for the study of β-catenin signaling, and it has been shown to inhibit cancer cells with high levels of β-catenin. It also inhibits tumor growth in mice by inhibiting the initiation phase of mitosis. In addition, DHP may be able to reduce the risk of escalation from colon cancer to metastatic colorectal cancer by targeting mitochondria. There are currently no clinical trials using this drug as an anti-cancer therapy. However, there are some data suggesting that this drug may be promising</p>

<p>Altertoxin III is a potent inhibitor of protein kinases that has shown promising results in the treatment of cancer. It is an analog of the natural compound Altertoxin, which was isolated from Chinese medicinal herbs. Altertoxin III has been shown to inhibit cyclin-dependent kinases (CDKs) and induce apoptosis in cancer cells. This inhibitor has also demonstrated anti-tumor activity in animal models, making it a promising candidate for further development as an anticancer agent. Additionally, Altertoxin III can be detected in human urine and may serve as a useful biomarker for monitoring cancer progression and response to therapy.</p>

<p>CBB1007 is a molecule that has been shown to inhibit the methylation and acetylation of lysine residues in proteins, which may be a potential biomarker for cancer. CBB1007 and its derivatives are being investigated as possible inhibitors of protein modification or as anticancer agents. In addition, CBB1007 has been shown to have anti-proliferative effects on cultured cells by inhibiting growth factor signaling pathways. This drug also inhibits tumor cell growth by inducing hypertrophy in the cells and up-regulating genes involved in cell cycle arrest.</p>

<p>9-(3-Hydroxypropoxy)guanine is an aldehyde oxidase inhibitor that blocks the production of formaldehyde, which is a reactive metabolite that can cause DNA damage. 9-(3-Hydroxypropoxy)guanine has been shown to inhibit the oxidation of purines in incubations with c1-6 alkyl. It also inhibits the oxidation of guanine and deoxyguanine mediated by aldehyde oxidase. This drug is a prodrug, which is converted to its active form in the cytosol by cytochrome p450 enzymes. The metabolic transformation of 9-(3-hydroxypropoxy)guanine into its active form occurs primarily in hepatocytes. 9-(3-Hydroxypropoxy)guanine has been shown to be effective against oxidative stress induced by homogenates and liver cells from humans, as well as cytosolic extracts from human hepatocytes.</p>

<p>GSK3179106 is a potent and selective inhibitor of the enzyme GSK3. It has been shown to have effects on acetylcholine levels, which may be due to its ability to modulate choline uptake. GSK3179106 has also been shown to inhibit cancerous growth by blocking the activation of the EGFR mutant in ganglion cells. This drug binds with high affinity to the receptor for acetylcholine at the neuromuscular junction and blocks neuronal function.</p>

<p>Peptide5 is a peptide that has been shown to have anti-inflammatory, neuroprotective, and anticancer properties. It also has the ability to alter calcium binding in vivo, which is associated with brain functions. Peptide5 has been shown to inhibit the growth of cancer cells by blocking uptake of amino acids into cells and tumor growth factor (TGF) production. The peptide can be used as an antigen for the production of monoclonal antibodies designed to treat infectious diseases and inflammatory disorders.</p>

<p>YM 90K hydrochloride is a voltage-gated calcium channel antagonist that blocks the influx of calcium ions into cells. It is a competitive inhibitor of the neurotransmitter glutamate and prevents neuronal death by inhibiting the release of glutamate. YM 90K hydrochloride has been shown to be clinically relevant in humans, as it binds to receptors on the surface of neurons and prevents voltage-dependent calcium channels from opening. This binding leads to an increase in the frequency of action potentials in the brain, which may lead to brain infarction. YM 90K hydrochloride also inhibits organic anion transporters (OAT) at higher doses, which leads to increased concentrations of estrone sulfate, a metabolite associated with hormone replacement therapy.</p>

<p>SB-200646A is a drug that has been shown to have selective affinity for the 5-HT2 receptor subtype. It has been shown to bind to this receptor in vivo and inhibit the binding of serotonin, which is known for its ability to stimulate dopamine release. SB-200646A has also been shown to have synergistic effects with other drugs that have dopamine antagonist properties. The drug has not been tested on humans, but it has been used in experimental models and in vivo models.</p>

<p>L-a-Phosphatidylinositol is a phospholipid that is found in the membranes of cells. It is also a precursor to many other important molecules, including platelet-derived growth factor (PDGF), which are involved in different cellular processes. L-a-Phosphatidylinositol has been shown to inhibit the growth of renal cell cancer cells and may be useful for the treatment of cancer. L-a-Phosphatidylinositol has been shown to be an effective inhibitor of influenza virus emissions and may be used as a prophylactic treatment for those who are at high risk for infection. This compound has also been linked with increased risk for renal cell cancer, although it is unclear whether this association is causal or not.</p>

<p>Mc-vc-pabc-aur0101 is a linker that has been designed to target cancer cells. It is composed of a peptide sequence and a site-specific antibody binding domain. Mc-vc-pabc-aur0101 modulates the activity of proteases, which are enzymes that break down proteins into smaller fragments. This linker can be conjugated to an antibody or other molecule, such as a drug or enzyme, and may also be used in combination with enzymatic modifications. Mc-vc-pabc-aur0101 has been shown to reduce the extracellular levels of proteases in mice with cancer cells, suggesting that this linker can target cancer cells by modifying their extracellular environment.</p>

<p>N-Palmitoyl(d9) D-erythro-sphingosine is a fatty acid that is used as a research tool for receptor and ligand binding assays. This product is also used in Cell Biology to study protein interactions and in Pharmacology as an inhibitor of ion channels. In the Life Science industry, it is used to study the effects of membrane fluidity on ion channel activity. N-Palmitoyl(d9) D-erythro-sphingosine has been shown to activate G protein coupled receptors and inhibit K+ channels in human cells. It also binds with high affinity to antibodies raised against peptides containing palmitic acid residues.</p>

<p>K-252D is a potent and selective antagonist of the voltage-gated potassium channel Kv2.1. It acts as an inhibitor of potassium ion channels and is used in research for studying the function of voltage-gated potassium channels.</p>

<p>Fluorescent dye for labeling amines</p>

<p>Activator of PDK1 kinase</p>

<p>ZK 261991 is a histone deacetylase inhibitor that has been shown to inhibit cell growth in vitro. It was also shown to have an inhibitory effect on the growth of pancreatic cancer cells in vivo and could be used as an adjuvant therapy for resection of pancreatic cancer. ZK 261991 is a potent inhibitor of the epidermal growth factor receptor, which is a tyrosine kinase receptor that is involved in the signaling pathway for cell proliferation and differentiation.</p>

<p>17-Hydroxy-17-(1-propyn-1-yl)estra-4,9-dien-3-one is a synthetic peptide that is a potent inhibitor of the protein interactions of the follicle stimulating hormone receptor (FSHR). The molecular structure of 17OHPED is similar to that of GnRH, and it is an agonist at the FSHR. 17OHPED has been shown to activate LHRH release in vitro and in vivo with large potency. It has also been shown to be a highly potent inhibitor of FSHR binding to its ligand, FSH. This compound can be used as a research tool for studying the interaction between proteins.</p>

<p>MI-463 is a drug that has been repurposed to treat cancer. It is a fatty acid that has been shown to have anticancer activity in vivo and in vitro. MI-463 targets the apoptosis pathway by inhibiting the activity of two proteins, caspases and FADD, which are involved in the initiation of apoptosis. In addition, MI-463 also inhibits the proliferation of cancer cells by decreasing levels of leukemic cell growth factor (LGF). MI-463 synergistically inhibits colonic adenocarcinoma cells with other drugs such as 5-fluorouracil or irinotecan.</p>

<p>SM 6586 is a dihydropyridine calcium antagonist that inhibits the entry of extracellular calcium into cells. It blocks the influx of calcium ions by blocking voltage-gated L-type calcium channels in smooth muscle cells and neurons. SM 6586 also interacts with other drugs. For example, it has been shown to inhibit the uptake of isradipine by rat brain synaptosomes and prevent isradipine from binding to its target site on the cell membrane. This drug also inhibits the transport of lysine analogs into cells, which may be due to its ability to inhibit cationic amino acid transporter activity.<br>SM 6586 has been shown to have an inhibitory effect on cerebral blood flow in both carotid arteries and ophthalmic veins. The mechanism behind this effect is not yet known.</p>

<p>Please enquire for more information about AZ1495 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about Godic including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>α2-adrenoceptor agonist; analgesic; sedative; anxiolytic</p>

<p>Tetraacetyl-2-(3-hydroxy-2-(3-hydroxypicolinamido)phenyl)benzo[D]oxazole-4-carboxylic acid is an antibacterial agent that inhibits the biosynthesis of 3-hydroxyanthranilic acid, a precursor to coryneform and leishmanial quinolones. Tetraacetyl-2-(3-hydroxy-2-(3-hydroxypicolinamido)phenyl)benzo[D]oxazole-4-carboxylic acid also inhibits the growth of Streptococcus species, Staphylococcus species, and Leishmania major. Tetraacetyl 2-(3-hydroxy-2-(3-hydroxypicolinamido)phenyl)benzo[D]oxazole 4 carboxylic acid has been shown to be active against C16 cells in vitro</p>

<p>Dechloroloxapine phosphate is a peptide that belongs to the class of protein ligands. It is an inhibitor of the muscarinic acetylcholine receptors and has been used as a research tool in cell biology, pharmacology, and life science. Dechloroloxapine phosphate binds to the receptor site on ion channels, thereby blocking their ability to open and close, inhibiting electrical current flow across the membrane. This peptide also interacts with antibodies and has been used as a reagent for immunological assays. Dechloroloxapine phosphate has a CAS number of 2058-53-9 and is made from pure material without any contaminants.</p>

<p>Nirogacestat is a secretase inhibitor that binds to the catalytic site of the enzyme, thereby preventing the cleavage of amyloid beta-protein into its toxic fragments. It has been shown to be effective in treating infectious diseases such as HIV infection, and also has anti-inflammatory properties. Nirogacestat also exhibits antitumor response in solid tumor models. Nirogacestat inhibits endothelial cell growth by blocking the release of angiogenic factors such as epidermal growth factor and VEGF. This drug also has an effect on body mass index and may have antiangiogenic properties.</p>

<p>Di-o-glycinoylcurcumin-d6 dihydrochloride is an isotopically labeled curcumin derivative, which is a compound used primarily in biochemical and pharmaceutical research. This product is synthesized in the laboratory, with deuterium atoms incorporated strategically to facilitate NMR spectroscopy studies and other analytical applications.</p>

<p>The compound is a cell factor that binds to the surface of tumour cells and initiates the process of apoptosis. It also has high resistance against sodium citrate, which is used as a preservative in human serum. The compound has been shown to have biological properties in solid tumours, such as human breast cancer and colon cancer. It also has been successfully used to control analysis for cancer tissues and a model system for studying the reaction solution. This drug can cause cell lysis in resistant breast cancer cells and is effective against other cancers like prostate, lung, pancreatic, ovarian, and cervical cancers.</p>

<p>Apremilast is a research tool that can be used to study the role of certain ion channels in cell biology. It can also be used as a ligand in receptor binding studies. Apremilast has been shown to have an inhibitory effect on ion channels, and it is also known to interact with proteins and peptides. This drug is not yet approved for use in humans, but it has been shown to be effective for the treatment of psoriatic arthritis.</p>

<p>Phe-Met-Arg-Phe amide trifluoroacetate is a high purity Receptor, Ligand, Activator that is used in research tool as a Cell Biology and Ion channels. It has CAS No. 159237-99-7, which makes it an Antibody, inhibitor of Protein interactions.</p>

<p>A cell-penetrating peptide toxin whose sequence is derived from wasp venom and a potent activator of heterotrimeric G proteins.<br>One letter code: INLKALAALAKKIL-NH2</p>

<p>Antagonist of CGRP receptor</p>

<p>Methyl 4,6-o-benzylidene-2-benzyloxycarbonylamino-2-deoxy-alpha-D-glucopyranoside is a research tool that binds to the activator, ligand, or receptor of a cell. It has been used to study ion channels and peptides. Methyl 4,6-o-benzylidene-2-benzyloxycarbonylamino-2-deoxy -alpha -D -glucopyranoside is also an inhibitor of protein interactions.</p>

<p>(+)-LY-338979 is a pharmacological agent that binds to the receptor site of ion channels and inhibits the activity of these channels. It has been shown to inhibit the potassium channels in a variety of cells, including neurons, cardiomyocytes, and vascular smooth muscle cells. (+)-LY-338979 has also been shown to activate ligand-gated ion channels, such as nicotinic acetylcholine receptors. This drug is used as a research tool for studies on ion channel function and it may have therapeutic potential for neurological diseases such as Alzheimer's disease and Parkinson's disease. (+)-LY-338979 is also an antibody that can be used for immunohistochemical detection of proteins.</p>

<p>Charybdotoxin is a peptide toxin that is found in scorpion venom. It acts as a potent inhibitor of the adenylyl cyclase, which is an enzyme that catalyzes the formation of cAMP from ATP. Charybdotoxin binds to the cavity of the enzyme and blocks access to ATP, preventing the accumulation of cAMP. This inhibition leads to a decrease in calcium ions in cells, and thus causes relaxation of smooth muscle tissue. Charybdotoxin has been shown to cause relaxation of bowel disease in mice by inhibiting contraction of intestinal muscle tissue. Charybdotoxin also has been shown to have therapeutic effects on pluripotent cells such as miapaca-2 cells by increasing their ability to form new blood vessels.</p>

<p>(R)-2-(N-Benzyl-4-(2-fluoroethoxy)phenylsulfonamido)-N-hydroxy-3-methylbutanamide is a fatty acid ester with a reactive functional group. It is used as a radiation sensitizer and has been shown to cause neuronal death in rats. This drug also inhibits the uptake of serotonin by neurons, which may be related to its cancer protective effects. (R)-2-(N-Benzyl-4-(2-fluoroethoxy)phenylsulfonamido)-N-hydroxy-3-methylbutanamide increases the alkoxy radical production in cells, which may contribute to its ability to suppress collagenase activity and matrix metalloproteinase in the skin.</p>

<p>1-(4-Fluorophenyl)-5-(4-methylsulfonylphenyl)pyrazole-3-carbonitrile is a high purity, cell biology research tool for protein interactions, ion channels, and receptor pharmacology. It is also used as an inhibitor or activator of the ligand binding site on a receptor. Ligands are small molecules that bind to receptors and activate them. 1-(4-Fluorophenyl)-5-(4-methylsulfonylphenyl)pyrazole-3-carbonitrile is an activator of the GABAA receptor and can be used in the treatment of epilepsy. This compound has been shown to have a potent inhibitory effect on peptide ligands, including bradykinin (BK), substance P (SP), and vasoactive intestinal polypeptide (VIP).</p>

<p>OSMI-4 is a synthetic substrate that can be used to study the enzymatic activity of O-glycosylation. It is a small molecule that can be incorporated into proteins and peptides in vitro, allowing for the study of O-glcnacylation. OSMI-4 has been shown to inhibit prostate cancer cell growth by ligation with an antigen receptor. This compound has also been shown to have regulatory effects on chronic lymphocytic leukemia cells, which may be due to its ability to inhibit glycolysis in these cells.</p>

<p>LB-100 is a cell-specific drug that has been shown to inhibit the growth of cancer cells in vitro. This drug has also been shown to have an antitumor response against bowel disease and inflammatory bowel disease, as well as an anti-inflammatory effect. LB-100 is a dinucleotide phosphate that has been activated by radiation, which increases its potency. The activation of LB-100 may be due to its ability to bind to nucleic acids and inhibit the synthesis of DNA or RNA. It has also been shown to have a pharmacological effect on meningioma and cervical cancer cells in vitro.<br>LB-100 is a low potency drug that inhibits the synthesis of DNA or RNA by binding to nucleic acids, but does not induce apoptosis or necrosis.</p>

<p>Progoitrin is a protein that has been found to have potential as an anticancer agent. It acts by inducing apoptosis, or programmed cell death, in cancer cells. Progoitrin also contains inhibitors that can inhibit the activity of certain enzymes involved in cancer cell growth and proliferation. This compound has been used in traditional Chinese medicine for its medicinal properties and has shown promising results in inhibiting tumor growth. Additionally, progoitrin has been found to have inhibitory effects on chitinase and heparinase, which may be useful for treating diseases such as asthma and thrombosis. Research has also shown that progoitrin can act as a kinase inhibitor, which could be useful for developing new treatments for cancer.</p>

<p>Methyl (2S,4aR,6aR,7R,9S,10aS,10Br)-9-carbamoyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f ]isochromene-7-carboxylate is a chemical compound that belongs to the class of fluoroquinolones. It is an inhibitor of the enzyme DNA gyrase and topoisomerase IV. This drug binds to bacterial 16S ribosomal RNA and inhibits protein synthesis leading to cell death by inhibiting the production of proteins vital for cell division. Methyl (2S,4aR)6aR7R9S10aS10Br)-9carbamoyloxy 2-(fur</p>

<p>Inhibits GLUT1 transporter</p>

<p>Cxcr7 modulator 2 is a ligand that activates the Cxcr7 receptor. It has been used for research purposes in cell biology, ion channels, and protein interactions. This molecule is also an inhibitor of the Cxcr7 receptor.</p>

<p>Please enquire for more information about Caspase 3 Substrate 1m (Apopain), fluorogenic including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Please enquire for more information about EC-18 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Bromodomain inhibitor-8 is a research tool used in pharmacology and cell biology. This inhibitor has been shown to inhibit ion channels and peptides, as well as to bind to receptors. It can be used as a ligand or an antibody to study protein interactions. Bromodomain inhibitor-8 is also a high purity reagent that is available for sale from Life Science.</p>

<p>BRD7/9 bromodomain inhibitor</p>

<p>WAY 100635 trihydrochloride is a selective serotonin 5-HT1A receptor antagonist, which is a compound used primarily in pharmacological research. It is a synthetic derivative with high specificity for the 5-HT1A receptor, originating from advanced organic chemistry processes. WAY 100635 trihydrochloride operates by competitively binding to the 5-HT1A receptors, thereby inhibiting the action of endogenous serotonin. This mode of action provides a valuable tool for scientists to study the physiological and pathological roles of the 5-HT1A receptor in the central nervous system.</p>

<p>N-[3-(1H-Imidazol-5-ylmethyl)phenyl]ethanesulfonamide is a ligand that binds to and activates the ion channel TRPV2. This compound is used in research as a tool for studying the function of ion channels. It has been shown to bind to and activate TRPV2 which is found in many cells, including human colon cancer cells. N-[3-(1H-Imidazol-5-ylmethyl)phenyl]ethanesulfonamide also binds to the receptor CXCR4 and inhibits cell proliferation, which may be due to its inhibition of protein synthesis. This active form is an agonist of the vasopressin V2 receptor and has been shown to inhibit the production of inflammatory cytokines such as IL-1β, IL-6, and TNFα.</p>

<p>A 844606 is a flavanones drug which has been shown to inhibit the proliferation of human tumor cells. It also induces tumor cell apoptosis and inhibits tumor growth in mice. A 844606 has been shown to bind to nicotinic acetylcholine receptors, and as such is an agonist for these receptors. It is a subtype-selective antagonist of nicotinic acetylcholine receptor subtypes α3β4 and α7, but not for α3β2. A 844606 has also been shown to have antitussive properties, indicating that it may be useful in the treatment of chronic obstructive pulmonary disease.</p>

<p>Inhibitor of dehydrosqualene synthase</p>

<p>Bombesin is a small peptide that was first isolated from the skin of a frog, Bombina bombina, with homologs later found to be present in mammalian tissues, including the brain and gastrointestinal tract. It is a member of the bombesin-like peptide family, which includes several related peptides such as gastrin-releasing peptide (GRP) and neuromedin B.<br>Bombesin acts as a neuromodulator and regulates various physiological functions, including gastrointestinal motility and stimulation of gastrin release from G cells. It also plays a role in the regulation of cardiovascular function and neurotransmitter release. In addition, bombesin has been shown to stimulate the growth and proliferation of certain types of cancer cells, including prostate and lung cancer cells, through its interaction with bombesin receptors. It may therefore be used as a potential biomarker for certain cancers.</p>

<p>Heat Shock Protein-90 alpha (HSP-90α) is a molecular chaperone protein that is involved in the folding and stabilization of proteins. HSP-90α is a member of the HSP family, which are known to be involved in many processes such as apoptosis, cell cycle regulation, DNA repair, and intracellular signaling. HSP-90α has been shown to inhibit the replication of viruses such as HIV by binding to viral proteins and preventing their assembly into virus particles. This protein also has antiviral effects on other viruses such as influenza and herpes simplex virus type 1.</p>

<p>2-Amino-3'-hydroxy-6'-{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}-2,3-dihydrospiro[isoindole-1,9'-xanthen]-3-one is a coumarin derivative that has been shown to have pharmacological effects in vivo. It can be used as a solvent for lipids and oils and is soluble in many organic solvents. The extraction yield of this compound is low because it has a high boiling point. This chemical is used as an intermediate in the synthesis of other drugs. 2-Amino-3'-hydroxy-6'-{2-[2-(2-hydroxyethoxy)ethoxy]ethoxy}-2,3-dihydrospiro[isoindole-1,9'-xanthen]-3-one also has surface methodology properties that are important for its use as an anti</p>

<p>IL-9 is a cytokine that is involved in the regulation of immune system. IL-9 signaling is essential for the induction of B cell responses and mast cell activation, and IL-9 is also expressed in epithelial cells. The IL-9 Mouse (CAS No. 207870-05-2) antibody reacts with IL-9 protein, which has a molecular weight of 18 kDa. This antibody detects an epitope corresponding to amino acids 1 to 13 of human Interleukin 9 (IL-9).</p>

<p>Avoralstat is a small molecule that inhibits the serine protease of angiogenic and neovascular cells. It is an extracellular, inhibitory mechanism, reactive, neovascular inhibitor that binds to the catalytic site of neovascular cells. Avoralstat has been shown to be effective in eye disorders such as age-related macular degeneration and diabetic retinopathy. The molecular modeling studies have shown avoralstat's binding mode with serine protease. Avoralstat also has diagnostic properties that can be used in various diagnostic agents for different conditions such as cancer and inflammation.</p>

<p>3-(3-Fluoro-4-hydroxyphenyl)-7-hydroxy-1-naphthonitrile (3F4) is a selective inhibitor of the estrogen receptor alpha. 3F4 blocks estrogen receptor alpha signaling, preventing the growth of breast cancer cells by blocking their ability to respond to estrogen. This agent also inhibits proliferation in other cancer cell lines and prolongs survival in mice with neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. 3F4 has been shown to inhibit microglial activation, which may be due to its ability to bind to the estrogen receptor alpha.</p>

<p>Please enquire for more information about Granisetron E including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>(S)-1-Acryloyl-4-(2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-7-(naphthalen-1-yl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)pipe razin-2-yl)acetonitrile is a small molecule that selectively inhibits the activation of a receptor for the neurotransmitter acetylcholine. It is synthesized by reacting (S)-1-(N′-(tertbutoxycarbonyl)glycyl)pyrrolidine with 1-[(2′,3′,5′,6′)-3-(acetyloxy)propyl]-4-(naphthalen-1 -yl)-5,6,7,8 tetrahydropyrido[3,4–d]pyrimidine</p>

<p>2,3,4,5,6-Pentafluoro-N-(4-hydroxy-3-phenylsulfanylnaphthalen-1-yl)benzenesulfonamide is a peptide inhibitor of the cAMP receptor protein that blocks the binding of cAMP to its receptor. This drug has been shown to be an activator of the beta2 adrenergic receptor. 2,3,4,5,6-Pentafluoro-N-(4-hydroxy-3-phenylsulfanylnaphthalen-1-yl)benzenesulfonamide has also been used as a research tool in cell biology and biochemistry for over two decades. It is characterized by high purity and stability.</p>

<p>BMS-1166 is a small molecule immunotherapy agent that functions as a PD-1 antagonist. It is derived from targeted drug design, focusing on disrupting the interaction between the programmed cell death protein 1 (PD-1) and its ligands, PD-L1 and PD-L2.</p>

<p>Actuator is a website that allows you to use an analogy to transfer data. It uses parameters, such as the section and analog, to calibrate the data transfer. The endpoint of the data transfer is the zooming function. This website also has an optical analogy that enables you to zoom in on a specific area of the screen. The data transfer can be initiated with a click of a button or by pressing enter on your keyboard.</p>

<p>Please enquire for more information about Calcitonin, rat including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>(R)-7-Chloro-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-(4-(dimethylamino)cyclohexyl)-2,4-dimethylbenzo[D][1,3]dioxole-5-carboxamide is a histone lysine methyltransferase inhibitor that has been shown to inhibit proliferation and induce apoptosis in cancer cells. It binds to the active site of the enzyme and prevents the transfer of methyl groups from S-adenosylmethionine to histone H3. This drug also inhibits protein kinases CDK4/6 and can be used as an anticancer drug.</p>

Vetynal Extra is a protein inhibitor that has shown promising results in the treatment of tumors and cancer. It works by inhibiting kinases, which are enzymes that play a key role in cell growth and division. By blocking these enzymes, Vetynal Extra can induce apoptosis or programmed cell death, which is an important mechanism for preventing the growth and spread of cancer cells. This anticancer drug is also effective against tolvaptan-resistant Chinese hamster ovary cells, making it a valuable addition to cancer treatment regimens. Additionally, Vetynal Extra has been shown to be effective in inhibiting the activity of human cancer cells, making it a promising candidate for further research into novel cancer therapies.

<p>A knockout mouse model of the SMI1 gene was used to study the effects of this gene on cancer onset and progression. The SMI1 protein is found in the cytosol and nucleus, where it regulates apoptosis and cell cycle progression. Knockout mice with a mutation in the SMI1 gene demonstrated increased autolysis, tumour growth, and tumour volume. These results suggest that SMI1 may be an effective target for therapeutic intervention.</p>

<p>Imipramine is a tricyclic antidepressant drug that is used to treat major depressive disorder, anxiety disorders, and chronic pain. Imipramine binds to the α1-acid glycoprotein receptor, which may be due to its ability to inhibit hydrogen bonding interactions with other inhibitor molecules. The rate constant of imipramine binding to the α1-acid glycoprotein receptor is high enough for this drug to have a significant effect on the rate of serotonin reuptake in the brain. Imipramine has been shown to have dna binding activity and can be detected in blood samples.br&gt;br&gt;Imipramine has been shown to cause drug interactions with drugs such as warfarin and other anticoagulants, which are metabolized by cytochrome P450 enzymes. Imipramine also interacts with drugs that are substrates for p-glycoprotein (e.g., digoxin) or CYP2D6 (e</p>

<p>Carbuterol is a peptide that is an inhibitor of protein interactions. Carbuterol is an activator of Ligand and receptor interactions and has been used as a research tool for studying ion channels. Carbuterol has been shown to be a potent inhibitor of the alpha-adrenergic receptor, which may be due to its ability to increase cyclic adenosine monophosphate (cAMP) levels in cells. Carbuterol has also been shown to have an inhibitory effect on the proteasome, which is responsible for degrading proteins within cells.</p>

<p>QX222 is a selective nicotinic acetylcholine receptor agonist that binds to the α7 nicotinic acetylcholine receptor. It is used as a research tool in neuroscience and physiology. QX222 has been shown to stimulate membrane hyperpolarization, which leads to an increase in cardiac action potentials. This drug also has dose-dependent effects on blood pressure and heart rate, which may be due to its ability to activate fatty acid metabolism and inhibit the binding of inhibitors to cation channels.</p>